MICHAEL LUND: Open Payments
NPI 1306815980 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,059 in 167 payments from 20 companies in 2025. Trend: 2023 $3,796 · 2024 $3,342 · 2025 $3,059
Food & beverage: $3,059
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $407 |
| E.R. Squibb & Sons, L.L.C. | 15 | $303 |
| Janssen Biotech, Inc. | 13 | $280 |
| PFIZER INC. | 13 | $250 |
| UCB, Inc. | 20 | $237 |
| Arcutis Biotherapeutics, Inc. | 17 | $226 |
| Incyte Corporation | 9 | $212 |
| Amgen Inc. | 9 | $179 |
| Novartis Pharmaceuticals Corporation | 10 | $172 |
| GENZYME CORPORATION | 5 | $153 |
Products named: Sotyktu, TREMFYA, CIBINQO, Bimzelx, Zoryve, RINVOQ, OPZELURA, SKYRIZI.
Industry payments across CT — which companies pay providers there.
